Growth Hormone and the Epithelial-to-Mesenchymal Transition

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  2017-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/jc.2017-01000PMID 28938477
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The basics of epithelial–mesenchymal transition (EMT): A study from a structure, dynamics, and functional perspective

  2019cited by this paper
• Antagonists of growth hormone-releasing hormone inhibit proliferation induced by inflammation in prostatic epithelial cells

  2017cited by this paper
• Tumour-Derived Human Growth Hormone As a Therapeutic Target in Oncology.

  2017cited by this paper
• Growth Hormone Receptor Knockdown Sensitizes Human Melanoma Cells to Chemotherapy by Attenuating Expression of ABC Drug Efflux Pumps

  2017cited by this paper
• Role of Growth Hormone in Breast Cancer

  2017cited by this paper
• Targeting growth hormone receptor in human melanoma cells attenuates tumor progression and epithelial mesenchymal transition via suppression of multiple oncogenic pathways

  2017cited by this paper
• Plasticity between Epithelial and Mesenchymal States Unlinks EMT from Metastasis-Enhancing Stem Cell Capacity

  2016cited by this paper
• Growth hormone receptor antagonism suppresses tumour regrowth after radiotherapy in an endometrial cancer xenograft model.

  2016cited by this paper
• Growth hormone is permissive for neoplastic colon growth

  2016cited by this paper
• Risk of malignant neoplasms in acromegaly: a case–control study

  2016cited by this paper
• Autocrine/Paracrine Human Growth Hormone-stimulated MicroRNA 96-182-183 Cluster Promotes Epithelial-Mesenchymal Transition and Invasion in Breast Cancer*

  2015cited by this paper
• Autocrine human growth hormone stimulates the tumor initiating capacity and metastasis of estrogen receptor-negative mammary carcinoma cells.

  2015cited by this paper
• Differential somatostatin receptor (SSTR) 1-5 expression and downstream effectors in histologic subtypes of growth hormone pituitary tumors.

  2015cited by this paper
• EMT is not required for lung metastasis but contributes to chemoresistance

  2015cited by this paper
• Growth Hormone Induces Transforming Growth Factor‐Beta‐Induced Protein in Podocytes: Implications for Podocyte Depletion and Proteinuria

  2015cited by this paper
• Enhanced epithelial to mesenchymal transition (EMT) and upregulated MYC in ectopic lesions contribute independently to endometriosis

  2015cited by this paper
• Growth hormone, insulin-like growth factor-1, and the kidney: pathophysiological and clinical implications.

  2014cited by this paper
• Growth Hormone and Reproduction: A Review of Endocrine and Autocrine/Paracrine Interactions

  2014cited by this paper
• Molecular mechanisms of epithelial–mesenchymal transition

  2014cited by this paper
• GP1-2: Autocrine human growth hormone suppression of E-CADHERIN via p44/42 MAPK promotes epithelial-tomesenchymal transition (EMT) of colorectal carcinoma cells

  2014cited by this paper
• Podocyte Dedifferentiation: A Specialized Process for a Specialized Cell

  2014cited by this paper
• MiR-183/-96/-182 cluster is up-regulated in most breast cancers and increases cell proliferation and migration

  2014cited by this paper
• Growth Hormone Is Secreted by Normal Breast Epithelium upon Progesterone Stimulation and Increases Proliferation of Stem/Progenitor Cells

  2014cited by this paper
• Growth hormone receptor inhibition decreases the growth and metastasis of pancreatic ductal adenocarcinoma

  2014cited by this paper
• IGF-1-induced epithelial-mesenchymal transition in MCF-7 cells is mediated by MUC1.

  2014cited by this paper
• Wnt/β-catenin signalling: from plasma membrane to nucleus.

  2013cited by this paper
• The expression and significance of insulin-like growth factor-1 receptor and its pathway on breast cancer stem/progenitors

  2013cited by this paper
• E‐ to N‐cadherin switch in melanoma is associated with decreased expression of phosphatase and tensin homolog and cancer progression

  2013cited by this paper
• Microenvironmental regulation of tumor progression and metastasis

  2013cited by this paper
• Constitutional Nephrin Deficiency in Conditionally Immortalized Human Podocytes Induced Epithelial-Mesenchymal Transition, Supported by β-Catenin/NF-kappa B Activation: A Consequence of Cell Junction Impairment?

  2013cited by this paper
• Increased thyroid cancer risk in acromegaly

  2013cited by this paper
• Regulatory networks defining EMT during cancer initiation and progression

  2013cited by this paper
• Protective role of growth hormone against hyperhomocysteinemia-induced glomerular injury

  2013cited by this paper
• Attenuated RORC Expression in the Presence of EMT Progression in Somatotroph Adenomas following Treatment with Somatostatin Analogs Is Associated with Poor Clinical Recovery

  2013cited by this paper
• The GH/IGF-1 axis in ageing and longevity

  2013cited by this paper
• Human metastatic melanoma cell lines express high levels of growth hormone receptor and respond to GH treatment.

  2013cited by this paper
• Epithelial–mesenchymal plasticity in carcinoma metastasis

  2013cited by this paper
• Wnt signaling in cancer.

  2012cited by this paper
• Epithelial-mesenchymal transition and breast cancer: role, molecular mechanisms and clinical impact.

  2012cited by this paper
• Epithelial Mesenchymal Transition in Drug Resistance and Metastasis of Lung Cancer

  2012cited by this paper
• Gene expression profiling identifies ESRP1 as a potential regulator of epithelial mesenchymal transition in somatotroph adenomas from a large cohort of patients with acromegaly.

  2012cited by this paper
• Podocyte Wnt/ß-catenin pathway is activated by integrin-linked kinase in clinical and experimental focal segmental glomerulosclerosis.

  2012cited by this paper
• Activation of STAT3 signal pathway correlates with twist and E-cadherin expression in hepatocellular carcinoma and their clinical significance.

  2012cited by this paper
• Reversal by Growth Hormone of Homocysteine-induced Epithelial-to-Mesenchymal Transition through Membrane Raft-Redox Signaling in Podocytes

  2011cited by this paper
• Tumor expression of human growth hormone and human prolactin predict a worse survival outcome in patients with mammary or endometrial carcinoma.

  2011cited by this paper
• Loss of E-Cadherin Expression and Outcome among Patients with Resectable Pancreatic Adenocarcinomas

  2011cited by this paper
• Oestrogen‐induced epithelial–mesenchymal transition of endometrial epithelial cells contributes to the development of adenomyosis

  2010cited by this paper
• The expression of E-cadherin in somatotroph pituitary adenomas is related to tumor size, invasiveness, and somatostatin analog response.

  2010cited by this paper
• The growth hormone receptor: mechanism of activation and clinical implications

  2010cited by this paper
• Growth Hormone (GH)-dependent Expression of a Natural Antisense Transcript Induces Zinc Finger E-box-binding Homeobox 2 (ZEB2) in the Glomerular Podocyte

  2010cited by this paper
• New insights into epithelial-mesenchymal transition in kidney fibrosis.

  2010cited by this paper
• A novel effect of growth hormone on macrophage modulates macrophage-dependent adipocyte differentiation.

  2010cited by this paper
• Thyroid cancer is the most common cancer associated with acromegaly

  2010cited by this paper
• Autocrine human growth hormone promotes tumor angiogenesis in mammary carcinoma.

  2009cited by this paper
• The basics of epithelial-mesenchymal transition.

  2009cited by this paper
• Reduced incidence and delayed occurrence of fatal neoplastic diseases in growth hormone receptor/binding protein knockout mice.

  2009cited by this paper
• Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions.

  2009cited by this paper
• Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984.

  2009cited by this paper
• Acromegaly, growth hormone and cancer risk.

  2008cited by this paper
• DNMT3A and DNMT3B mediate autocrine hGH repression of plakoglobin gene transcription and consequent phenotypic conversion of mammary carcinoma cells

  2008cited by this paper
• Increased nuclear expression of growth hormone receptor in uterine cervical neoplasms of women under 40 years old.

  2008cited by this paper
• The Contribution of Growth Hormone to Mammary Neoplasia

  2008cited by this paper
• The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2.

  2008cited by this paper
• Role of the GH/IGF-1 axis in lifespan and healthspan: lessons from animal models.

  2008cited by this paper
• Autocrine human growth hormone stimulates oncogenicity of endometrial carcinoma cells.

  2008cited by this paper
• Extracellular matrix protein betaig-h3/TGFBI promotes metastasis of colon cancer by enhancing cell extravasation.

  2008cited by this paper
• The GH-IGF1 axis and longevity. The paradigm of IGF1 deficiency

  2008cited by this paper
• Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria.

  2008cited by this paper
• AlphaCP1 mediates stabilization of hTERT mRNA by autocrine human growth hormone.

  2007cited by this paper
• Nuclear targeting of the growth hormone receptor results in dysregulation of cell proliferation and tumorigenesis

  2007cited by this paper
• Mechanisms of metastasis: Epithelial‐to‐mesenchymal transition and contribution of tumor microenvironment

  2007cited by this paper
• Constitutively Active Type I Insulin-Like Growth Factor Receptor Causes Transformation and Xenograft Growth of Immortalized Mammary Epithelial Cells and Is Accompanied by an Epithelial-to-Mesenchymal Transition Mediated by NF-κB and Snail

  2007cited by this paper
• αCP1 Mediates Stabilization of hTERT mRNA by Autocrine Human Growth Hormone*

  2007cited by this paper
• The epithelial–mesenchymal transition: new insights in signaling, development, and disease

  2006cited by this paper
• Human growth hormone and interleukin-6 are upregulated in endometriosis and endometrioid adenocarcinoma.

  2006cited by this paper
• Oncogenic transformation of human mammary epithelial cells by autocrine human growth hormone.

  2005cited by this paper
• Gene Expression Profiling to Identify Oncogenic Determinants of Autocrine Human Growth Hormone in Human Mammary Carcinoma*

  2005cited by this paper
• Functional consequences of integrin-linked kinase activation in podocyte damage.

  2005cited by this paper
• Dual regulation of Snail by GSK-3β-mediated phosphorylation in control of epithelial–mesenchymal transition

  2004cited by this paper
• Phenotypic conversion of human mammary carcinoma cells by autocrine human growth hormone.

  2004cited by this paper
• Cell adhesion and signalling by cadherins and Ig-CAMs in cancer

  2004cited by this paper
• The oncogenic potential of autocrine human growth hormone in breast cancer.

  2004cited by this paper
• Human Growth Hormone-regulated HOXA1 Is a Human Mammary Epithelial Oncogene*

  2003cited by this paper
• Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models.

  2003cited by this paper
• BMP-7 counteracts TGF-β1–induced epithelial-to-mesenchymal transition and reverses chronic renal injury

  2003cited by this paper
• Autocrine Human Growth Hormone Inhibits Placental Transforming Growth Factor-β Gene Transcription to Prevent Apoptosis and Allow Cell Cycle Progression of Human Mammary Carcinoma Cells*

  2002cited by this paper
• Morphogenic and tumorigenic potentials of the mammary growth hormone/growth hormone receptor system.

  2002cited by this paper
• The Transcriptional Factor Tcf-4 Contains Different Binding Sites for β-Catenin and Plakoglobin*

  2002cited by this paper
• High stromal and epithelial human gh gene expression is associated with proliferative disorders of the mammary gland.

  2002cited by this paper
• γ-Catenin expression is reduced or absent in a subset of human lung cancers and re-expression inhibits transformed cell growth

  2002cited by this paper
• Epithelial–mesenchymal transitions in tumour progression

  2002cited by this paper
• Autocrine Human Growth Hormone (hGH) Regulation of Human Mammary Carcinoma Cell Gene Expression

  2001cited by this paper
• Effect of tamoxifen on GH and IGF-1 serum level in stage I-II breast cancer patients.

  2001cited by this paper
• Integrin linked kinase as a candidate downstream effector in proteinuria

  2001cited by this paper
• Serum insulin‐like growth factor‐I and breast cancer

  2000cited by this paper
• Autocrine human growth hormone enhancement of human mammary carcinoma cell spreading is Jak2 dependent.

  2000cited by this paper
• The transcription factor Snail controls epithelial–mesenchymal transitions by repressing E-cadherin expression

  2000cited by this paper
• Increased expression of growth hormone and prolactin receptors in hepatocellular carcinomas

  2000cited by this paper
• Inhibitory action on GHRH‐induced GH secretion of chronic tamoxifen treatment in breast cancer

  2000cited by this paper
• Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.

  2000cited by this paper

• The role of growth hormone in metastasis and angiogenesis of breast cancer.

  2026cites this paper
• Growth Hormone, Not Simply Just a Hormone for Growth.

  2026cites this paper
• CCL2 expression predicts clinical outcomes, and regulates E-cadherin and angiogenesis in pituitary tumours.

  2025cites this paper
• Targeting Growth Hormone Receptor to Overcome Therapy Resistance in Non-Small Cell Lung Cancer

  2025cites this paper
• Growth Hormone Signaling in Bladder Cancer: Transcriptomic Profiling of Patient Samples and In Vitro Evidence of Therapy Resistance via ABC Transporters and EMT Activation

  2025cites this paper
• Excess endocrine growth hormone in acromegaly promotes the aggressiveness and metastasis of triple-negative breast cancer

  2024cites this paper
• Growth Hormone Action as a Target in Cancer: Significance, Mechanisms and Possible Therapies.

  2024cites this paper
• Growth Hormone Upregulates Melanoma Drug Resistance and Migration via Melanoma-Derived Exosomes

  2024cites this paper
• Growth Hormone Receptor Antagonist Markedly Improves Gemcitabine Response in a Mouse Xenograft Model of Human Pancreatic Cancer

  2024cites this paper
• The Role of Programmed Cell Death Ligand 1 Expression in Pituitary Tumours: Lessons from the Current Literature

  2024cites this paper
• Reactive oxygen species and ovarian diseases: Antioxidant strategies

  2023cites this paper
• WIP1 is a novel specific target for growth hormone action

  2023cites this paper
• Non-pituitary GH regulation of the epithelial microenvironment.

  2023cites this paper
• Tumour microenvironment and pituitary tumour behaviour

  2023cites this paper
• Updates in neuroendocrine neoplasms: from mechanisms to the clinic.

  2023cites this paper
• Small molecules to regulate the GH/IGF1 axis by inhibiting the growth hormone receptor synthesis

  2022cites this paper
• The microenvironment of pituitary adenomas: biological, clinical and therapeutical implications

  2022cites this paper
• Epigenetic regulation of epithelial to mesenchymal transition: a trophoblast perspective.

  2022cites this paper
• Recent advancements in the molecular biology of pituitary adenomas

  2022cites this paper
• Covert actions of growth hormone: fibrosis, cardiovascular diseases and cancer

  2022cites this paper
• Growth hormone receptor antagonism downregulates ATP-binding cassette transporters contributing to improved drug efficacy against melanoma and hepatocarcinoma in vivo

  2022cites this paper
• Hormone supply to the pituitary gland: A comprehensive investigation of female-related tumors (Review)

  2022cites this paper
• Exogenous growth hormone promotes an epithelial-mesenchymal hybrid phenotype in cancerous HeLa cells but not in non-cancerous HEK293 cells

  2022cites this paper
• Follow, consider, and catch: second primary tumors in acromegaly patients

  2022cites this paper
• SLC7A5 Promotes Colorectal Cancer Progression by Regulating Cell Cycle and Migration

  2021cites this paper
• Epithelial–Mesenchymal Transition in the Resistance to Somatostatin Receptor Ligands in Acromegaly

  2021cites this paper
• A Cancer Cell Cluster Marked by LincRNA MEG3 Leads Pancreatic Ductal Adenocarcinoma Metastasis

  2021cites this paper
• Dual Characters of GH-IGF1 Signaling Pathways in Radiotherapy and Post-radiotherapy Repair of Cancers

  2021cites this paper
• Consistency of Pituitary Adenoma: Prediction by Pharmacokinetic Dynamic Contrast-Enhanced MRI and Comparison with Histologic Collagen Content

  2021cites this paper
• GH and IGF System: The Regulatory Role of miRNAs and lncRNAs in Cancer

  2021cites this paper
• 3D interactions with the growth hormone locus in cellular signalling and cancer-related pathways

  2020cites this paper
• Postmenopausal dense breasts maintain premenopausal levels of GH and insulin-like growth factor binding proteins in vivo.

  2020cites this paper
• Enhanced Bioactivity of a Human GHR Antagonist Generated by Solid-Phase Site-Specific PEGylation.

  2020cites this paper
• Growth Hormone Upregulates Mediators of Melanoma Drug Efflux and Epithelial-to-Mesenchymal Transition In Vitro and In Vivo

  2020cites this paper
• Growth Hormone Receptor Regulation in Cancer and Chronic Diseases

  2020cites this paper
• THE TUMOUR MICROENVIRONMENT OF PITUITARY NEUROENDOCRINE TUMOURS.

  2020cites this paper
• Long-acting human growth hormone receptor antagonists produced in E. coli and conjugated with polyethylene glycol.

  2020cites this paper
• 3D interactions with the GH locus in cellular signalling and cancer-related pathways.

  2020cites this paper
• 3D interactions with the growth hormone locus in cellular signalling and cancer-related pathways

  2020cites this paper
• Higher order genomic organization and epigenetic control maintain cellular identity and prevent breast cancer

  2019cites this paper
• Excess growth hormone suppresses DNA damage repair in epithelial cells.

  2019cites this paper
• Targeting growth hormone function: strategies and therapeutic applications

  2019cites this paper
• Growth hormone in the tumor microenvironment

  2019cites this paper
• The Microenvironment of Pituitary Tumors—Biological and Therapeutic Implications

  2019cites this paper
• The effects of growth hormone on therapy resistance in cancer

  2019cites this paper
• Pathogenesis and Diagnosis of Growth Hormone Deficiency in Adults.

  2019cites this paper
• Tumor microenvironment defines the invasive phenotype of AIP-mutation-positive pituitary tumors

  2019cites this paper
• Growth Hormone Upregulates Melanocyte-Inducing Transcription Factor Expression and Activity via JAK2-STAT5 and SRC Signaling in GH Receptor-Positive Human Melanoma

  2019cites this paper
• MECHANISMS IN ENDOCRINOLOGY: Lessons from growth hormone receptor gene-disrupted mice: are there benefits of endocrine defects?

  2018cites this paper
• Growth Hormone's Links to Cancer.

  2018cites this paper
• Growth Hormone (GH) and Gonadotropin-Releasing Hormone (GnRH) in the Central Nervous System: A Potential Neurological Combinatory Therapy?

  2018cites this paper